https://www.selleckchem.com/pr....oducts/pf-2545920.ht
INTRODUCTION AND OBJECTIVES Abnormal serum iron studies are seen in a third or more of patients with chronic hepatitis C infection (HCV), where they have been linked to accelerated fibrosis progression and increased risk of hepatocellular carcinoma and sometimes lead to concern for coexisting hereditary hemochromatosis. The aim of this study was to assess the effect of HCV eradication in patients with abnormal serum iron studies prior to treatment with direct-acting antiviral agents (DAAs). PATIENTS HCV-infected subjects with iron st
Like
Comment
Share
